Does Pirtobrutinib 100 Mg Tablet Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- P-GLYCOPROTEIN (P-GP) INHIB/COLCHICINE (CARDIOPROTECTION)
- WEAK CYP3A4 INHIBITORS/LEMBOREXANT (> 5 MG)
- WEAK CYP3A4 INHIBITORS/LOMITAPIDE (>30 MG)
- SELECTED IMMUNOSUPPRESSANTS/TALIMOGENE LAHERPAREPVEC
- SELECTED IMMUNOSUPPRESSIVE AGENTS/LIVE VACCINES; LIVE BCG
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/EFALIZUMAB; NATALIZUMAB
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- PIRTOBRUTINIB/STRONG CYP3A4 INHIBITORS
- PIRTOBRUTINIB/STRONG CYP3A4 INDUCERS
- PIRTOBRUTINIB/MODERATE CYP3A4 INDUCERS
- MODERATE CYP2C8 INHIBITORS/TOVORAFENIB
- P-GLYCOPROTEIN (P-GP) INHIBITORS/VINCRISTINE
- IMMUNOSUPPRESSIVE CYP2C8 INHIBITORS/ETRASIMOD
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/RITLECITINIB
- PIRTOBRUTINIB/LONAFARNIB
- P-GLYCOPROTEIN (P-GP) INHIBITORS/BILASTINE
- P-GLYCOPROTEIN (P-GP) INHIBITORS/DOXORUBICIN
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/CLADRIBINE
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/SIPONIMOD
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/OZANIMOD
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/FINGOLIMOD
- P-GP INHIBITORS/RIMEGEPANT
- MYELOSUPPRESSIVES; IMMUNOMODULATORS/SODIUM IODIDE I 131
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/FILGOTINIB
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/PONESIMOD
- SELECTED IMMUNOSUPPRESSANTS/LEFLUNOMIDE; TERIFLUNOMIDE
- P-GLYCOPROTEIN (P-GP) INHIBITORS/RELUGOLIX
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/BARICITINIB
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/INEBILIZUMAB
- P-GLYCOPROTEIN (P-GP) INHIBITORS/ORAL LEFAMULIN
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/UPADACITINIB
- WEAK CYP3A4 INHIBITORS/ELIGLUSTAT
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/VENETOCLAX
- P-GLYCOPROTEIN (P-GP) INHIBITORS/COLCHICINE
- IMMUNOSUPPRES;IMMUNOMODUL/SELECTED MULTIPLE SCLEROSIS AGENTS
- SELECTED MYELOSUPPRESSIVE AGENTS/CLOZAPINE
- WEAK CYP3A4 INHIBITORS/LOMITAPIDE (<=30MG)
- SELECTED CYP2C19 INHIBITORS/CLOPIDOGREL
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/TOFACITINIB
- SELECTED MYELOSUPPRESSIVE AGENTS/DEFERIPRONE
- SELECT CYP2C19 INHIBITORS/CITALOPRAM (>20 MG)
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/ALISKIREN
- P-GLYCOPROTEIN (P-GP) INHIBITORS/TOPOTECAN
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/DABIGATRAN
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- MODERATE CYP2C8 INHIBITORS/RESMETIROM
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/TOCILIZUMAB
- PIRTOBRUTINIB/ROSUVASTATIN
- MODERATE CYP2C8 INHIBITORS/DAPRODUSTAT
- PIRTOBRUTINIB/DIGOXIN
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/UBLITUXIMAB
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/SARILUMAB
- SLT MODERATE AND WEAK CYP3A4 INHIBIT/SIROLIMUS PROTEIN-BOUND
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/COVID-19 VACCINES
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/USTEKINUMAB
- WEAK CYP3A4 INHIBITORS/UBROGEPANT
- WEAK CYP3A4 INHIBITORS/LEMBOREXANT (<= 5 MG)
- MODERATE AND WEAK CYP3A4 INHIBITORS/TACROLIMUS
- SELECTED CYP2C19 INHIBITORS/ESCITALOPRAM (<= 15 MG)
- SELECT P-GP INHIBITORS/EDOXABAN (<= 30 MG)
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/BETRIXABAN
- SELECT P-GP INHIBITORS/EDOXABAN (> 30 MG)
- SELECTED CYP2C19 INHIBITORS/ESCITALOPRAM (> 15 MG)
- SELECTED CYP2C19 INHIBITORS/CITALOPRAM (<= 20 MG)
- SELECTED P-GP AND WEAK CYP3A4 INHIBITORS/RIVAROXABAN
- MODERATE CYP3A4; P-GP INHIBITORS/EVEROLIMUS
- CYP3A4; CYP2C8; P-GLYCOPROTEIN (P-GP) INHIBITORS/LOPERAMIDE
- SELECTED P-GLYCOPROTEIN (P-GP) INHIBITORS/ETOPOSIDE
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.